Anzeige
Mehr »
Login
Freitag, 17.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
1.078 Leser
Artikel bewerten:
(2)

Magna International Inc.: Magna Advances Road Safety With Impaired Driving Prevention Technology

Finanznachrichten News
  • Technology to help enhance detection of impaired driving, a leading cause of traffic-related fatalities in the U.S.
  • The passive system approach uses both vision and infrared sensor technology
  • Cockpit-embedded sensors and camera system measure alcohol from a driver's exhaled breath and through pupillary signals

AURORA, Ontario, Jan. 09, 2024 (GLOBE NEWSWIRE) -- At CES 2024, leading mobility technology company Magna introduced a breath and camera-based pre-development technology designed to combat impaired driving. The cutting-edge solution represents a significant milestone in the ongoing efforts to enhance road safety.

The new safety technology determines if drivers are "fit to drive" in a fast, reliable and affordable way. The integrated solution combines key elements of the interior sensing system, which utilizes camera technology to detect driver distraction, drowsiness and intoxication through pupillary signals, with infrared sensor technology developed by Senseair, a leader in air and gas sensing.

Magna Impaired Driving Prevention Technology

New impaired driving prevention technology uses a combination of vision and breath-based technologies

Cockpit-embedded sensors, placed in proximity to the driver, measure and quantify the alcohol and carbon dioxide levels in diluted exhalations from the driver. The technology is intended to passively detect an intoxicated driver with a blood alcohol concentration at or above the legal limit of 0.08 percent in all states except Utah, where the legal limit is 0.05 percent.

"As we continue to support the company's vision of advancing mobility for everyone, our team is focused on delivering active safety innovations that help reduce accidents and fatalities," said Bill Snider, President of Electronics at Magna. "We are working with our customers and the industry to take a significant step forward in making the roads safer for all who share them."

Drunk driving claimed more than 13,000 lives in 2021 or about one-third of all traffic-related deaths in the U.S., according to the National Highway Traffic Safety Administration. Magna's new solution focuses on alcohol detection, the most common substance associated with impaired driving crashes.

During CES, the company will provide outdoor demonstrations of this technology by appointment only at booth WP-42 in the West Plaza Parking lot of the Las Vegas Convention Center. For more information on this and other Magna technologies on display at CES, visit www.magna.com/CES2024.

TAGS
CES 2024, Driver Monitoring, Impairment Detection, Safety, Electronics, Product & Technology

INVESTOR CONTACT
Louis Tonelli, Vice-President, Investor Relations
louis.tonelli@magna.com, 905-726-7035

MEDIA CONTACT
Tracy Fuerst, Vice President, Corporate Communications & PR
tracy.fuerst@magna.com, 248-761-7004

ABOUT MAGNA
Magna is more than one of the world's largest suppliers in the automotive space. We are a mobility technology company built to innovate, with a global, entrepreneurial-minded team of over 181,000 employees across 344 manufacturing operations and 104 product development, engineering and sales centres spanning 29 countries. With 65+ years of expertise, our ecosystem of interconnected products combined with our complete vehicle expertise uniquely positions us to advance mobility in an expanded transportation landscape.

For further information about Magnaor follow us on social.

THIS RELEASE MAY CONTAIN STATEMENTS WHICH CONSTITUTE "FORWARD-LOOKING STATEMENTS" UNDER APPLICABLE SECURITIES LEGISLATION AND ARE SUBJECT TO, AND EXPRESSLY QUALIFIED BY, THE CAUTIONARY DISCLAIMERS THAT ARE SET OUT IN MAGNA'S REGULATORY FILINGS. PLEASE REFER TO MAGNA'S MOST CURRENT MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL POSITION, ANNUAL INFORMATION FORM AND ANNUAL REPORT ON FORM 40-F, AS REPLACED OR UPDATED BY ANY OF MAGNA'S SUBSEQUENT REGULATORY FILINGS, WHICH SET OUT THE CAUTIONARY DISCLAIMERS, INCLUDING THE RISK FACTORS THAT COULD CAUSE ACTUAL EVENTS TO DIFFER MATERIALLY FROM THOSE INDICATED BY SUCH FORWARD-LOOKING STATEMENTS. THESE DOCUMENTS ARE AVAILABLE FOR REVIEW ON MAGNA'S WEBSITE AT WWW.MAGNA.COM.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/22f67d82-1412-44d7-8b6a-6ef03b72250a


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.